Harry M. Greenblatt
- Pharmacology top 0.5%
- Molecular Biology top 10%
- Computational Theory and Mathematics top 0.5%
- Organic Chemistry top 5%
- Plant Science top 10%
- Co-authors
- Joel L. SussmanIsrael SilmanGitay KrygerG. ShohamT. LewisYaakov LevyHay DvirBoris Brumshtein
- Topics
- Cholinesterase and Neurodegenerative Diseases (17 papers)Computational Drug Discovery Methods (16 papers)Peptidase Inhibition and Analysis (9 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyNucleic Acids Research
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Harry M. Greenblatt
46 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 107
- Pharmacology 1.1k
- Molecular Biology 1.1k
- Computational Theory and Mathematics 748
- Organic Chemistry 707
- Plant Science 352
Countries citing papers authored by Harry M. Greenblatt
This map shows the geographic impact of Harry M. Greenblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry M. Greenblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry M. Greenblatt more than expected).
Fields of papers citing papers by Harry M. Greenblatt
This network shows the impact of papers produced by Harry M. Greenblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry M. Greenblatt. The network helps show where Harry M. Greenblatt may publish in the future.
Co-authorship network of co-authors of Harry M. Greenblatt
This figure shows the co-authorship network connecting the top 25 collaborators of Harry M. Greenblatt. A scholar is included among the top collaborators of Harry M. Greenblatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry M. Greenblatt. Harry M. Greenblatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 35 | |
| 3 | 16 | |
| 4 | 30 | |
| 5 | 9 | |
| 6 | 11 | |
| 7 | 16 | |
| 8 | 4 | |
| 9 | 100 | |
| 10 | 167 | |
| 11 | 48 | |
| 12 | 31 | |
| 13 | 6 | |
| 14 | 97 | |
| 15 | 32 | |
| 16 | 259 | |
| 17 | 27 | |
| 18 | 41 | |
| 19 | 16 | |
| 20 | 68 |
About Harry M. Greenblatt
Harry M. Greenblatt is a scholar working on Pharmacology, Computational Theory and Mathematics and Organic Chemistry, having authored 46 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (17 papers), Computational Drug Discovery Methods (16 papers) and Peptidase Inhibition and Analysis (9 papers). The work is most often cited by research in Pharmacology (1.1k citations), Computational Theory and Mathematics (748 citations) and Organic Chemistry (707 citations). Harry M. Greenblatt has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Joel L. Sussman, Israel Silman, Gitay Kryger, G. Shoham, T. Lewis, Yaakov Levy, Hay Dvir, Boris Brumshtein, Yuan‐Ping Pang and Dawn M. Wong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.